Abstracts Management of Metastatic Carcinoma* T. S. Ravikumar, MD Metastatic liver tumors are a spectrum of disease categories: many histologic types of primary cancers as well as varying numbers of tumors at diagnosis. It is no surprise that the treatment of liver metastasis comprises a large spectrum of options. The surgeon plays a significant role in the management of liver metastasis wherein the liver remains the only site of failure or the dominant site of disease until the time of death. Metastasis from colorectal cancer and neuroendocrine tumors of the gastrointestinal tract form the two important histologic types where the liver-directed approach has been demonstrated to be useful. Among the regional approaches discussed here are: resection, hepatic artery infusion chemotherapy and in situ tumor ablation techniques. Despite the paucity of Level 1 evidence (ie, a lack of multiple randomized prospective trials with consistent data), the data from prospective/retrospective analysis from multiple centers demonstrate that hepatic resection in patients with a limited number of metastases from colorectal cancer and select other primary sites, results in long-term survival in most, and cure in many patients. Adjunctive chemotherapy may improve the long-term cure of patients with metastatic colorectal cancer post hepatic resection. Ablative techniques such as Cryosurgery and RFA are useful in the surgeonís repertoire for palliation and potential cure of liver tumors, which are respectable for curative intent. Prospective trials are needed to validate the role of ablative strategies as well as to find optimal combinations of resection, ablation, HAI and systemic therapy. Improved patient selection and tumor discrimination by high quality imaging modalities such as 18FDG PET may further improve outcome. The presence of infected central necrosis was the main indicator that a patient would require eventual pancreatic surgery. Central necrosis was present in 41% of patients and only 29% of these were cured with PD. The remaining patients required pancreatic surgery. Abstracts "Dome Down" Laparoscopic Cholecystectomy Glenn L. Sandler, MD Endoscopic Drainage of Pancreatic Pseudocyst Gary C. Vitale, MD Thoracoscopic Splanchnicectomy for Pancreatic Pain Henry L. Laws, MD CT Guided Percutaneous Drainage of Infected Acute Necrotizing Pancreatitis Patrick C. Freeny, MD Management of Metastatic Carcinoma T. S. Ravikumar, MD Management of Liver Trauma Juan C. Asensio, MD Management of Benign Liver Tumors Leslie H. Blumgart, MD, FRCS Role and Techniques of "Dome-Down" Laparoscopic Cholecystectomy Glenn L. Sandler, MD Thoracoscopic Splanchnicectomy for Pancreatic Pain Henry L. Laws, MD Current ConceptsæAdequate Pain Management Young K. Choi, MD Prevention and Management of Infection Complicating Acute Pancreatitis Henry L. Laws, MD Indication for and Timing of ERCP in Biliary Pancreatitis John Baillie, MB, ChB, FRCP Timing of Laparoscopic Cholecystectomy After Biliary Pancreatitis Gary C. Vitale Magnetic Resonance Angiography Martin R. Prince, MD, PhD Pancreatic Imaging Patrick C. Freeny, MD Endoscopic Ultrasonography Charles Noyer, MD Limited Gastric Resection Jo Buyske, MD Current ConceptsæManagement of Pancreatic Carcinoma Henry A. Pitt, MD Watchful Waiting in the Management of Inguinal Hernia Robert J. Fitzgibbons, MD Treatment of Incisional (Ventral) Hernias: Open Repair Maximo Deysine, MD, FACP Treatment of Incisional (Ventral) Hernias: Laparoscopic Repair Adrian E. Park, MD Indications for Converting to Open Operation John G. Hunter, MD Medicolegal Implications of Common Bile Duct Injury During Laparoscopic Cholecystectomy Kenneth A. Kern, MD, FACS Role and Technique of Pylorus Preserving Pacreatectomy Henry A. Pitt, MD